| Issuer | % of Class | Filed |
|---|---|---|
|
Eupraxia Pharmaceuticals Inc.
13D/A
Amendment 2
EPRX · 29842P105
|
9.0% |
3/16/2026
Event 3/13/2026
|
|
Eupraxia Pharmaceuticals Inc.
13D/A
Amendment 1
EPRX · 29842P105
|
10.2% |
9/26/2025
Event 9/24/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.